Abstract: Pure compound screening has identified the dioxothiazino-quinoline-quinone ascidian metabolite ascidiathiazone A (2) to be a moderate growth inhibitor of Trypanosoma brucei rhodesiense (IC 50 3.1 μM) and Plasmodium falciparum (K1 dual drug resistant strain) (IC 50 3.3 μM) while exhibiting low levels of cytotoxicity (L6, IC 50 167 μM). A series of C-7 amide and Δ 2(3) analogues were prepared that explored the influence of lipophilicity and oxidation state on observed anti-protozoal activity and selectivity. Little variation in anti-malarial potency was observed (IC 50 0.62-6.5 μM), and no correlation was apparent between anti-malarial and anti-T. brucei activity. Phenethylamide 7e and Δ 2(3) -glycine analogue 8k exhibited similar anti-Pf activity to 2 but with slightly enhanced selectivity (SI 72 and 93, respectively), while Δ 2(3)
Introduction
Natural products have historically played an important role in the discovery of new treatments for malaria [1] . From quinine and artemisinin [2, 3] starting points, a diverse range of anti-malarials have been developed and have been the mainstay of frontline treatment for decades. Unfortunately with time has come loss of therapeutic efficacy due to the growing prevalence of drug resistant strains [4] . In the hunt for novel scaffolds from which to develop the next generation of anti-malarials, a structurally-diverse array of natural products, including those obtained from marine organisms, have been reported to exhibit activity towards Plasmodium falciparum [5] [6] [7] .
As part of our own continuing search for new leads for the development of treatments for neglected human diseases [8] [9] [10] [11] [12] we have screened a library of synthesized and isolated marine natural products against a panel of four parasitic protozoa: Trypanosoma brucei rhodesiense, Trypanosoma cruzi, Leishmania donovani and Plasmodium falciparum K1 dual drug-resistant strain, with concurrent counter-screening for toxicity towards the non-malignant L6 rat myoblast cell line. We recently disclosed details of the first hit from this screen, the previously reported anti-inflammatory polyamine diamide ascidian metabolite orthidine F (1) [13] [14] [15] (Figure 1 ). A second series of hits identified in this screening program were ascidiathiazone A (2), also previously reported by us as an anti-inflammatory alkaloid from a New Zealand ascidian, and synthetic analogues 3 and 4 [16] . The anti-protozoal evaluation of 2 (Table 1, entry 1) established the natural product to be a moderately potent in vitro growth inhibitor of P. falciparum K1 strain (IC 50 3.3 μM) and Trypanosoma brucei rhodesiense (IC 50 3.1 μM) while being effectively inactive towards T. cruzi and Leishmania donovani and exhibiting low levels of cytotoxicity against a mammalian cell-line (L6, IC 50 170 μM). Similar levels of potency and selectivity were observed for ester 3 ( Table 1, with enhanced selectivity (SI Pf 300). Herein we report the results of a preliminary structure-activity relationship study investigating the influence of C-2 amide functionalization and thiazine-Δ 2(3) oxidation on the biological activity of 2. In addition, we report that novel furan and thiophene analogues of 2 exhibit potent in vitro anti-malarial activity and that one analogue exhibits in vivo activity towards P. berghei. h cLogP calculated using ALOGPS 2.1, as described in [17, 18] ;
i Melarsoprol, benznidazole, miltefosine, chloroquine and podophyllotoxin were used as positive controls.
Results and Discussion

Chemistry
We undertook a preliminary structure-activity relationship study to explore the effect of carboxylic acid functionalization and thiazine ring oxidation state towards the observed anti-protozoal activity of 2. Efforts to directly prepare amide derivatives of 2 by reaction of the synthesized natural product [16] with various amines in the presence of peptide coupling reagents, led to the formation of complex product mixtures and low yields (data not shown). Instead we made use of a longer four step reaction sequence (Scheme 1). Commercially available 8-hydroxyquinoline-2-carboxylic acid was converted to amides 5a-5j by reaction with the appropriate amine using PyBOP as the coupling agent in DMF. Subsequent oxidation using PIFA (phenyliodine bis(trifluoroacetate)) in MeCN/H 2 O yielded unstable quinones 6a-6j. Scheme 1. General reaction sequence for the preparation of analogues 7a-j and 8a-k. Reagents and conditions: (i) PIFA (2-3 equiv.), MeCN/H 2 O, 0 °C, 20 min; (ii) Hypotaurine (0.8 equiv.), CeCl 3 · 7H 2 O, MeCN/EtOH, rt, 2 days; (iii) 2 N NaOH, DMF, rt, 2 h; (iv) SOCl 2 , MeOH, 0 °C then rt, then 65 °C, 2 h, 93% yield.
Previous studies by ourselves [16, 19] and others [20, 21] have found that hypotaurine addition to quinones typically yields a mixture of regio-isomeric thiazine adducts. In the present study, we found that slow addition of a dilute solution of hypotaurine in MeCN/EtOH at room temperature afforded, after filtration and washing, analogues 7a-7j in yields of 14%, 27%, 57%, 17%, 49%, 57%, 29%, 29%, 26% and 20%, respectively. The regio-isomeric identity of the product in each case was established by 2D-NMR data, particularly HMBC experiments optimized for 8.3 and 2.0 Hz, which showed correlations from H-9 to quinone C-10 (8.3 Hz) and from NH-4 to quinone C-5 (2.0 Hz) [16] . Reaction of each of 7a-7j with 2 N NaOH in DMF for 2 h [16] afforded the desired hydrolysed and autoxidised Δ 2(3) -thiazine analogues 8a-8i and 8k in variable yield (30%-83%). In the specific case of the glycine methylester 7j the product of this reaction was the Δ 2(3) -thiazino carboxylic acid 8k, methylation of which (SOCl 2 , MeOH, 93% yield) afforded ester 8j. Thiophene analogues of ascidiathiazone A were prepared (Scheme 2) starting from the literature quinone 9 [22] . Reaction with hypotaurine yielded two isomeric products 10a and 10b in a ratio of 1:0.3, as determined by NMR. Despite extensive attempts using chromatography, the isomers could not be separated and so were used as a mixture in the following steps. The regio-isomeric identity of 10a and 10b could not be established, as no relevant long range 1 H-13 C correlations were observed in HMBC data. Acid-mediated ester hydrolysis afforded carboxylic acids 11a and 11b, again characterized as an inseparable 1:0.3 mixture. HMBC data obtained for this isomeric mixture however was able to establish that the major regio-isomer was 11a as shown. Thus correlations observed between the major isomer H-8 resonance (δ H 7.84) to quinonoid resonance δ C 171.7 (C-9) and from the thiazine NH (δ H 9.31) to a second quinonoid resonance δ C 173.1 (C-5) confirmed the identity of 11a.
In the case of base hydrolysis/autoxidation, reaction of the isomeric mixture 10a/10b with 1N NaOH in a biphasic reaction in EtOAc, yielded the expected Δ 2(3) product 12. Column chromatography in this case was successful in affording the major regio-isomeric product in pure form. HMBC data analysis, in particular the observation of correlations from H-2 (δ H 6.57) and H-8 (δ H 7.82) to the same quinonoid carbon resonance at δ C 175.2 (C-9) established the dioxothiazine ring regiochemistry of 12 as shown.
A series of furan analogues were prepared in analogous fashion, this time starting from commercially available 7-methoxy-benzofuran-2-carboxylic acid ethyl ester 13 (Scheme 3). Oxidation using acidified ceric ammonium sulfate afforded quinone 14 in 85% yield. Slow addition of hypotaurine to the quinone afforded a single regio-isomer 15 of the expected dioxothiazine product (43% yield). As demonstrated earlier, acidic hydrolysis of ester 15 yielded the carboxylic acid 16 (63% yield), while biphasic 1N NaOH/EtOAc hydrolysis and autoxidation afforded the Δ 2(3) carboxylic acid 17 in 47% yield. 
Biological Activities
In Vitro Biological Evaluation
The library of target analogues were screened against a set of four protozoa and for cytotoxicity towards the rat skeletal myoblast cell line L6 and the results are summarized in Table 1 (amide and  oxidized analogues of 2) and Table 2 (thiophene and ester analogues). All of the amide analogues 7a-h,j evaluated were either equipotent or slightly more active against P. falciparum than the natural product 2. A similar observation was made for activities towards T. brucei rhodesiense, except for propargyl 7h (Table 1 , entry 11) and glycyl ester 7j (Table 1 , entry 12) both of which were significantly less active than 2. Notable in this series, unfortunately, was the lack of selectivity with most analogues exhibiting selectivity indices (SI) of 40 or less. Of this sub-set, only phenethyl amide 7e ( Table 1 , entry 8) exhibited anti-protozoal activity and cytotoxic selectivity similar to those observed for 2. The corresponding Δ 2(3) analogues 8a-k while being typically equipotent or slightly more active against P. falciparum, were on the whole more cytotoxic with low selectivity. Significant amongst the series were the Δ 2(3) phenethyl amide 8e (Table 1 , entry 17), which was the most active anti-T. brucei rhodesiense analogue, and ether 8i, ester 8j and carboxylic acid 8k (Table 1 , entries 21-23) which maintained the anti-Pf activity of 2 but with modestly enhanced selectivity. There was no apparent correlation between calculated logP and observed biological activity (Table 1) . Thiophene and furan analogues 10a/10b, 11a/11b, 12, and 15-17 were evaluated against the same selection of protozoa and for cytotoxicity ( Table 2) . Potent anti-Pf activity was observed for the thiophene examples, with the isomerically pure carboxylic acid 12 ( [23] , a repeated ip dose of 50 (mg/kg)/day for four days led to an 85.7% reduction in parasitaemia, and an increase in mean survival time from 4-6 days (untreated control) to 9.6 days. Switching to an oral dosing experiment (100 mg/kg once per day for 4 days) yielded a 47% reduction of parasitaemia. Although not considered significant, these levels of activity for both ip and po dosing clearly identifies heterocyclic dioxothiazinoquinone carboxylic acids to be a novel anti-malarial drug scaffold warranting further structure-activity relationship studies.
Experimental Section
General
HRMS data were acquired on a Bruker micrOTOF-QII mass spectrometer. Infrared spectra were recorded on a Perkin-Elmer Spectrum 100 Fourier-transform IR spectrometer equipped with a universal ATR accessory. Melting points were obtained on an Electrothermal melting point apparatus and are uncorrected. NMR spectra were recorded using either a Bruker Avance DRX 300 or 400 spectrometer operating at 300 MHz or 400 MHz for 1 [22] have been reported previously.
Synthetic Procedures
General Procedure for the Preparation of 8-Hydroxyquinoline-2-carboxamides 5a-5j
To a solution of 8-hydroxyquinoline-2-carboxylic acid and PyBOP (1.25 equiv.) in dry DMF (3-6 mL), amine (1-2 equiv.) and triethylamine (1.25 equiv.) were added under N 2 . The reaction mixture was then stirred under N 2 at rt for 12 h, after which time the mixture was dried in vacuo. The residue was purified by reversed-phase C 18 flash column chromatography (0%-80% MeOH in H 2 O (0.05% TFA)) and silica gel column chromatography (0%-1% MeOH in CH 2 Cl 2 ).
N-n-Butyl-8-hydroxyquinoline-2-carboxamide (5a)
From 8-hydroxyquinoline-2-carboxylic acid (100 mg, 0.529 mmol), PyBOP (330 mg, 0.64 mmol), n-butylamine (104 µL, 1.05 mmol) and triethylamine (88 µL, 0.632 mmol) in DMF (6 mL) to give 5a as a yellow oil (108 mg, 84% yield). 
General Procedure for Preparation of Quinones 6a-6j
A solution of PIFA (2-3 equiv.) in MeCN/H 2 O (2:1 mL) was cooled to 0 °C, followed by the addition of the appropriate 8-hydroxyquinoline-2-carboxamide in CH 2 Cl 2 (1 mL). The dark brown suspension was stirred for 20 min. at 0 °C before being poured into a mixture of CH 2 Cl 2 (20 mL) and H 2 O (30 mL). The organic phase was dried in vacuo and the crude product used in the subsequent reaction without further purification. 
N-n-Pentyl-5,8-dioxo-5,8-dihydroquinoline-2-carboxamide (6b)
From N-n-pentyl-8-hydroxyquinoline-2-carboxamide (5b) (38 mg, 0.15 mmol), PIFA (127 mg, 0.30 mmol) to give 6b (31 mg, 76% yield) as a brown oil. 
N-(2-Methoxyethyl)-5,8-dioxo-5,8-dihydroquinoline-2-carboxamide (6i) From N-(2-methoxyethyl)-8-hydroxyquinoline-2-carboxamide
N-Glycine(methylester)-5,8-dioxo-5,8-dihydroquinoline-2-carboxamide (6j)
From N-glycine(methylester)-8-hydroxyquinoline-2-carboxamide (5j) (50 mg, 0.19 mmol), PIFA (132 mg, 0.31 mmol) to give 6j (40 mg, 77% yield) as a brown oil. 
General Procedure for the Preparation of Carboxamide Analogues 7a-7j
A solution of 5,8-dioxo-5,8-dihydroquinoline-2-carboxamide (6a-6j) was dissolved in MeCN/EtOH (1:1) before being cooled to 0 °C. In some cases, CeCl 3 · 7H 2 O (1 equiv.) was also added to the reaction. Hypotaurine (0.8 equiv.) in H 2 O was added dropwise over 3.5 h. The reaction mixture changed color from dark brown to dark orange, and was stirred at rt for 2 days. The product was purified either by filtration and washing with H 2 O (3 × 20 mL) and MeOH (3 × 20 mL), or by reversed-phase C 18 flash column chromatography (0%-80% MeOH in H 2 O (0.05% TFA)). [1, 4] thiazino [2,3- 
N-n-Butyl-5,10-dioxo-3,4,5,10-tetrahydro-2H-
N-n-Pentyl-5,10-dioxo-3,4,5,10-tetrahydro-2H
- [1, 4] thiazino [2,3- 
General Procedure for Preparation of Δ 2(3) Analogues 8a-8i, 8k
Thiazine-quinoline-carboxamide (7a-7j) in DMF (1-3 mL) was stirred in 2 N NaOH (3 mL) at rt for 2 h. HCl (10% vol) was added dropwise until the reaction mixture was pH 5 and the mixture was then purified by reversed-phase C 18 flash column chromatography (0%-10% MeOH (0.05% TFA)) to give the desired product.
3.2.4.1. N-n-Butyl-5,10-dioxo-5,10-dihydro-4H- [1, 4] thiazino [2,3- [1, 4] thiazino [2,3-g] Thionyl chloride (8.4 µL, 0.116 mmol) was added to a solution of 8k (7.0 mg, 0.019 mmol) in dry MeOH (3 mL) at 0 °C. The reaction mixture was stirred at that temperature for 20 min, then heated to 65 °C and stirred for an additional 2 h. The solution was then cooled to rt and loaded directly onto a C 18 reversed-phase chromatography column. The crude material was washed with two column volumes of H 2 O and the product eluted with 100% MeOH (+0.05% TFA) to afford 8j as a yellow oil (6.8 mg, 93% yield). Methyl ester (as a mixture of regioisomers) 10a/10b (20.0 mg, 0.061 mmol) was dissolved in conc. HCl (3 mL), and stirred at rt for 5 h, after which time, the mixture was heated to 100 °C and stirred for a further 2 h. The crude reaction mixture was subjected to reversed-phase C 18 column chromatography (0%-10% MeOH/H 2 O (0.05% TFA)) to give 11a/11b as a mixture of regioisomers (1:0.3, 11.0 mg, 57% yield) as a bright orange solid. 
